XML 79 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
INTEREST EXPENSE NON-RELATED PARTIES AND OTHER EXPENSE (INCOME), NET
9 Months Ended
Sep. 30, 2015
Interest Income (Expense), Net [Abstract]  
Other Income and Other Expense Disclosure [Text Block]
21.
INTEREST EXPENSE NON-RELATED PARTIES AND OTHER EXPENSE (INCOME), NET
 
For the three months ended September 30, 2015, non-related parties interest expense of $9,254 is comprised of $9,177 interest on convertible debentures and $77 other interest. For the three months ended September 30, 2014, non-related parties interest expense of $10,312 is comprised of $10,216 interest on convertible debentures and $96 other interest.
 
For the nine months ended September 30, 2015, non-related parties interest expense of $27,800 is comprised of $27,531 interest on convertible debentures and $269 other interest. For the nine months ended September 30, 2014, non-related parties interest expense of $35,564 is comprised of $34,702 interest on convertible debentures and $862 other interest.
 
For the three months ended September 30, 2015, $6,494 other income, net is comprised of $7,200 legal settlement receivable and no other individually significant items. For the three months ended September 30, 2014, $26,223 other income, net is comprised primarily of $49,812 sales commissions, partially offset by $20,406 headquarters and manufacturing facility relocation expense, and $3,183 other expense, net of individually insignificant items
 
For the nine months ended September 30, 2015, $4,264 other income, net is comprised primarily of $7,200 legal settlement (see Note 16. COMMITMENTS AND CONTINGENCIES), $3,471 royalty income on licensed patents, $1,800 sale of fixed assets, $2,930 other income, net of individually insignificant items and is partially offset by $11,137 insurance expense audit adjustments. For the nine months ended September 30, 2014, $23,619 other income, net is comprised primarily of $49,812 sales commissions, $31,463 write off of accrued legal expense from prior years resulting from resolution of overbilling as identified by Company, $5,144 royalty income on licensed patents, and partially offset by $20,406 headquarters and manufacturing facility relocation expense, $27,846 loss on disposal of fixed assets, and $14,850 loss on convertible debenture settlement.